Summit Medical gets FDA clearance for University of Minnesota-based jaw fracture recovery device

6 June 2017 (Last Updated June 6th, 2017 18:30)

Summit Medical has obtained the US Food and Drug Administration (FDA) clearance for the University of Minnesota's (U of M), US, jaw fracture device called Minne Ties Agile MMF.

Summit Medical gets FDA clearance for University of Minnesota-based jaw fracture recovery device

Summit Medical has obtained the US Food and Drug Administration (FDA) clearance for the University of Minnesota's (U of M), US, jaw fracture device called Minne Ties Agile MMF.

Developed based on a research technology by former U of M senior innovation fellow Dr Alan Johnson, the device is designed for the non-invasive recovery of jaw fracture.

Minne Ties Agile features a collection of sutures that are inserted between the teeth to allow secure and even fixation of the jaw, and aiding proper recovery.

Summit Medical president Kevin McIntosh said: “It is extremely rewarding to be a part of a disruptive technology that is redefining the industry and making a positive impact on patients, surgeons and hospital teams.

"Unlike existing wire-based methods, which may cause abrasions on the lips and gums, and gingivitis, the new device’s sutures come with a smooth clasp head and a blunt tip to minimise gum irritation and dental hygiene concerns."

“Working with the University of Minnesota and Dr Johnson on commercialising Minne Ties has been a thoroughly positive experience."

Unlike existing wire-based methods, which may cause abrasions on the lips and gums, and gingivitis, the new device’s sutures come with a smooth clasp head and a blunt tip to minimise gum irritation and dental hygiene concerns.

The sutures are claimed to enable quick and easy application with little discomfort.

Dr Johnson developed the Minne Ties technology in 2012, while it was later licenced for further development by Summit Medical in 2014.


Image: Minne Ties Agile MMF model. Photo: courtesy of Summit Medical Inc.